Get Level 2

Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Oncimmune Share Price
  4. Oncimmune Share Regulatory News

Pin to quick picksOncimmune Regulatory News (ONC)

Oncimmune Information
  • This share is currently suspended. It was suspended at a price of 1.2699
  • There is currently no data for ONC
12345678
Date   Source Headline
20th May 202212:11 pmRNSHolding(s) in Company
18th May 202211:46 amRNSHolding(s) in Company
5th May 20225:32 pmRNSHolding(s) in Company
3rd May 20226:10 pmRNSHolding(s) in Company
26th Apr 20224:26 pmRNSHolding(s) in Company
21st Apr 20227:00 amRNSQueen’s Award for Enterprise in Innovation 2022
14th Apr 202212:24 pmRNSExercise of Options, PDMR Dealing and TVR
8th Apr 20227:00 amRNSTwo further ImmunoINSIGHTS contracts signed
4th Apr 20222:43 pmRNSHolding(s) in Company
29th Mar 20224:46 pmRNSExercise of Options, PDMR Dealing and TVR
18th Mar 20223:01 pmRNSHolding(s) in Company
16th Mar 20227:00 amRNSBlock Listing Six Monthly Return
15th Mar 20227:00 amRNSExercise of Warrants and Total Voting Rights
9th Mar 20224:08 pmRNSHolding(s) in Company
7th Mar 20222:10 pmRNSPDMR Dealing
7th Mar 20227:00 amRNSFollow-on contract to validate previous profiling
4th Mar 20227:00 amRNSImmunoINSIGHTS contract signed with global pharma
1st Mar 20227:00 amRNSImmunoINSIGHTS and Synexa partnership
28th Feb 20227:05 amRNSInterim Results
28th Feb 20227:00 amRNSContract signed with Verily Life Sciences
25th Feb 20227:00 amRNSNotice of Half Year Results
21st Feb 20223:14 pmRNSHolding(s) in Company
17th Feb 20227:00 amRNSEarlyCDT Lung approved and adopted in Aragon Spain
15th Feb 20227:00 amRNSImmunoINSIGHTS commercial update
31st Dec 20217:00 amRNSResults from COVID-19 autoantibody profiling panel
24th Dec 20217:00 amRNSPDMR Dealing
22nd Dec 202111:10 amRNSGrant of Options and PDMR Dealing
21st Dec 202111:34 amRNSPDMR Dealing
21st Dec 20217:00 amRNSImmunoINSIGHTS commercial update
20th Dec 20213:13 pmRNSTotal Voting Rights
7th Dec 20217:00 amRNSCommercial momentum in ImmunoINSIGHTS
26th Nov 20214:41 pmRNSSecond Price Monitoring Extn
26th Nov 20214:36 pmRNSPrice Monitoring Extension
26th Nov 202110:36 amRNSResults of Annual General Meeting
3rd Nov 20217:00 amRNSNotice of AGM and posting of Annual Report
2nd Nov 20217:00 amRNSFull year results and progress update
2nd Nov 20217:00 amRNSChange of Adviser
27th Oct 20214:35 pmRNSPrice Monitoring Extension
25th Oct 20214:40 pmRNSSecond Price Monitoring Extn
25th Oct 20214:35 pmRNSPrice Monitoring Extension
25th Oct 20217:00 amRNSNotice of Full Year results
20th Sep 20217:00 amRNSAgreement with pharma company to profile patients
15th Sep 202111:08 amRNSBlock Listing Six Monthly Return
23rd Aug 20217:00 amRNSThree-year follow-up data for the ECLS trial
23rd Jul 20217:00 amRNSAgreement signed with major cancer center
22nd Jul 20217:00 amRNSValidation of ImmunoINSIGHTS service in COVID-19
1st Jul 20217:00 amRNSTotal Voting Rights
8th Jun 20217:00 amRNSFull Year Trading Update
28th May 20217:30 amRNSNotice of FY21 Trading Update
5th May 20217:03 amRNSReturn of China Rights to EarlyCDT
12345678

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
NAS
North Atl.smlr
LSE
1.27%
CPR
CPR.L
LSE
0.00%
PRTC
PureTech
LSE
1.67%
13JS
Eu Invest Bank
LSE
0.00%
IPE
IPE.L
LSE
0.00%
Trending
MCG
Mobico Group
LSE
3.51%
ARS
Asiamet Resources Limited
LSE
0.62%
TLW
Tullow Oil
LSE
-1.13%
CBG
Close Bros
LSE
-0.27%
RRR
Red Rock Resources
LSE
4.35%